checkAd

     215  0 Kommentare Aquestive Therapeutics Receives Complete Response Letter from FDA for Libervant (diazepam) Buccal Film for Management of Seizure Clusters - Seite 5


      
    PharmFilm and the Aquestive logo are registered trademarks of Aquestive Therapeutics, Inc. All other registered trademarks referenced herein are the property of their respective owners.

    Investor Inquiries:
    Stephanie Carrington
    stephanie.carrington@icrinc.com
    646-277-1282


    Lesen Sie auch

    Diskutieren Sie über die enthaltenen Werte


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 5 von 5

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Aquestive Therapeutics Receives Complete Response Letter from FDA for Libervant (diazepam) Buccal Film for Management of Seizure Clusters - Seite 5 Complete Response Letter cites exposure levels (Cmax) in certain weight groupsNo additional clinical studies anticipated by AquestiveNo Clinical Safety issues or Non-Clinical Chemistry, Manufacturing and Controls (CMC) issues identifiedConference …